Apolipoprotein AI Monoklonaler Antikörper

Apolipoprotein AI Monoklonal Antikörper für WB, IHC, IF/ICC, FC (Intra), Indirect ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, IF/ICC, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1C9G5

Kat-Nr. : 66206-1-PBS

Synonyme

APOA1, apolipoprotein A I, 1C9G5, APOA 1, ApoA I



Geprüfte Anwendungen

Produktinformation

66206-1-PBS bindet in WB, IHC, IF/ICC, FC (Intra), Indirect ELISA Apolipoprotein AI und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen Apolipoprotein AI fusion protein Ag21920
Vollständiger Name apolipoprotein A-I
Berechnetes Molekulargewicht 31 kDa
Beobachtetes Molekulargewicht 26-28 kDa
GenBank-ZugangsnummerBC005380
Gene symbol APOA1
Gene ID (NCBI) 335
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

ApoA1 is a major protein component of high density lipoproteins (HDL) which is associated with reversed cholesterol transport, lipid/cholesterol binding, lecithin/cholesterol acyltransferase (LCAT) activation and specific receptors binding. It is synthesized in the liver and small intestine. Defects of ApoA1 cause low HDL level and systemic non-neuropathic amyloidosis. Serum concentration of ApoA1 is inversely related to the risk of developing atherosclerosis. This antibody was generated against the C-terminal region of human ApoA1.